Suchergebnisse

The upcoming report from Kamada (KMDA) is expected to reveal quarterly earnings of $0.12 per share, indicating a decline of 7.7% compared to the year-ago period. Analysts forecast revenues of

Kamada (KMDA) came out with quarterly earnings of $0.16 per share, beating the Zacks Consensus Estimate of $0.12 per share. This compares to earnings of $0.13 per share a year ago. These figures are

For the quarter ended June 2026, Kamada (KMDA) reported revenue of $54.92 million, up 22.7% over the same period last year. EPS came in at $0.16, compared to $0.13 in the year-ago quarter.

The

Shares of Kamada (KMDA) have gained 5.1% over the past four weeks to close the last trading session at $7.26, but there could still be a solid upside left in the stock if short-term price targets of

Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop

Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with Kamada (KMDA) and Prothena (PRTA). But which of these two companies is the best option for those looking for

Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. However, it isn't easy to